COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 1340: Articles 13391-13400  | Next

Dynamics of COVID-19 pandemic in India and Pakistan: A metapopulation modelling approach
Brozak, S. J., Pant, B., Safdar, S., Gumel, A. B.
10.1101/2021.08.02.21261459 — Posted: 2021-08-05
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
Israel, A., Merzon, E., Schäffer, A. A., Shenhar, Y., Green, I., Golan-Cohen, A., Ruppin, E., Magen, E., Vinker, S.
10.1101/2021.08.03.21261496 — Posted: 2021-08-05 Discussion: Onsite | Offsite
Sensitive and multiplexed RNA detection with Cas13 droplets and kinetic barcoding
Son, S., Lyden, A., Shu, J., Stephens, S. I., Fozouni, P., Knott, G. J., Smock, D. C. J., Liu, T. Y., Boehm, D., Simoneau, C., Kumar, R., Doudna, J. A., Ott, M., Fletcher, D. A.
10.1101/2021.08.02.21261509 — Posted: 2021-08-05
COVID-19 impact on stroke admissions during France's first epidemic peak: an exhaustive, nationwide, observational study
Risser, C., Tran Ba Loc, P., Binder-Foucard, F., Fabacher, T., Lefevre, H., Sauvage, C., Sauleau, E., Wolff, V.
10.1101/2021.08.03.21261438 — Posted: 2021-08-05
Temporal Geospatial Analysis of COVID-19 Pre-infection Determinants of Risk in South Carolina
Lyu, T., Hair, N., Yell, N., Li, Z., Qiao, S., Liang, C., Li, X.
10.1101/2021.08.02.21261500 — Posted: 2021-08-05
Challenges in Tracking the Risk of COVID-19 in Bangladesh: Evaluation of A Novel Method
Hoque, E., Islam, M. S., Sharma, A. S., Islam, R., Amin, M. R.
10.1101/2021.08.03.21261567 — Posted: 2021-08-05
Optical nanoscopy reveals SARS-CoV-2-induced remodeling of human airway cells
Nijenhuis, W., Damstra, H. G. J., van Grinsven, E. J., Iwanski, M. K., Praest, P., Soltani, Z. E., van Grinsven, M. M. P., Brunsveld, J. E., De Kort, T. M., Rodenburg, L. W., de Jong, D. C. M., Raeven, H. M., Spelier, S., Amatngalim, G. D., Akhmanova, A., Nijhuis, M., Lebbink, R. J., Beekman, J. M., Kapitein, L. C. M.
10.1101/2021.08.05.455126 — Posted: 2021-08-05
But Mouse, you are not alone: On some severe acute respiratory syndrome coronavirus 2 variants infecting mice
Kuiper, M. J., Wilson, L., Mangalaganesh, S., Reti, D., Vasan, S. S.
10.1101/2021.08.04.455042 — Posted: 2021-08-05
Pandemic-Scale Phylogenomics Reveals Elevated Recombination Rates in the SARS-CoV-2 Spike Region
Turakhia, Y., Thornlow, B., Hinrichs, A. S., Mcbroome, J., Ayala, N., Ye, C., De Maio, N., Haussler, D., Lanfear, R., Corbett-Detig, R.
10.1101/2021.08.04.455157 — Posted: 2021-08-05
Virucidal activity of CPC-containing oral rinses against SARS-CoV-2 variants and are active in the presence of human saliva
Anderson, E. R., Patterson, E. I., Richards, S., Green, A. K., Mukherjee, S., Hoptroff, M., Hughes, G.
10.1101/2021.08.05.455040 — Posted: 2021-08-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).